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Abstract
By acting through its receptors (RXFP1, RXFP2), relaxin (RLN) exerts species-specific
effects during pregnancy; possible luteotropic effects through stimulation of prolactin (PRL)
release have been suggested. In the domestic dog (Canis lupus familiaris) serum PRL
increases in pregnant bitches shortly after RLN appears in the circulation, and a possible
functional relationship between the RLN and the PRL systems in regulating progesterone
secretion has been implied. Therefore, here (Study 1) the luteal expression and localization
of the RLN system was investigated by immunohistochemistry using custom-made antibod-
ies and semi-quantitative PCR, at selected time points during gestation: pre-implantation (d.
8–12), post-implantation (d. 18–25), mid-gestation (d. 35–40) and at normal and antigesta-
gen-induced luteolysis. Further, (Study 2) hypophyseal expression of the RLN system and
its spatial association with PRL was assessed. Luteal expression of RLN, but not of its
receptors, was time-dependent: it increased significantly following implantation towards
mid-gestation and decreased at prepartum. Antigestagen treatment resulted in downregula-
tion of RLN and RXFP2. Whereas RLN was localized in steroidogenic cells, RXFP1 and
RXFP2 also stained strongly in macrophages and vascular endothelial cells. The RLN sys-
tem was detected in the canine adenohypophysis and was co-localized with PRL in hypo-
physeal lactotrophs. The intraluteal RLN seems to be involved in regulating the canine
corpus luteum (CL) in a time-dependent manner. The presence of RLN family members in
the adenohypophysis implies their possible involvement in regulating the availability of PRL
and other pituitary hormones.
Introduction
The peptide hormone relaxin (RLN) is involved in pregnancy-related remodeling of connec-
tive tissue [reviewed in [1, 2]]. Acting on the pubic ligament, pregnant uterus and uterine cer-
vix, RLN participates in preparing the birth canal for parturition, thereby facilitating the
course of labor. Although these effects of RLN are well-known and broadly described, several
other actions of RLN are known to be species- and/or organ-specific. For instance, RLN was
shown to be involved in decidualization and implantation in women [3, 4]. It was also found
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to act locally in an auto- and paracrine manner in the ovary by regulating follicular develop-
ment in pigs [5] and humans [6] and, possibly, promoting ovulation in rats [7, 8]. In addition,
due to the systemic distribution of its receptors, RXFP1 and RXFP2, the functions of RLN
appear to spread beyond the reproductive tract [2].
RXFP1 and RXFP2 are members of the G-protein coupled receptor family (GPCRs). It is
noteworthy that RLN is a cognate ligand for RXFP1, however it can bind and activate RXFP2
for which the main ligand is insulin-like peptide 3 (INSL3) [9]. The primary source of RLN is
distinct for each species and can be localized in the corpus luteum (CL), placenta or uterus [1].
Moreover, besides its main origins, RLN is also synthesized in other reproductive organs,
referred to as secondary sources, e.g., the ovary in mares [10] or the placenta in women [11].
These organs regulate their own function by local, auto- or paracrine secretion of RLN, with-
out however contributing strongly to its circulating levels.
In contrast to other species like the pig, human or rat, in the domestic dog (Canis lupus
familiaris), RLN is detectable only during gestation [12], which renders this hormone a useful
endocrine diagnostic marker of pregnancy in this species. RLN becomes detectable in the
blood around day 20–25 of pregnancy, peaks 2–3 weeks before whelping and stays elevated
until term [13]. It originates predominantly from the placenta [14]. As revealed in our recent
study [15], its major source appears to be cytotrophoblast. In the same study [15], RLN synthe-
sis was confirmed in the uterus, i.e., endometrium and myometrium. Additionally, luteal
expression of RLN mRNA and protein was previously reported [14, 16] in the dog. However,
the CL seems to be a rather secondary source of RLN in this species, since ovariectomy per-
formed during pregnancy does not affect circulating RLN [14].
The canine CL is an indispensible endocrine organ for pregnancy maintenance [17]. It is
the only provider of progesterone (P4) in this species since the placenta is devoid of steroido-
genic capacity [18, 19]. Progesterone secretion patterns are similar in pregnant and pseudo-
pregnant dogs [18, 20]. The corresponding hormone levels vary widely individually, tending,
however, to be higher during pregnancy [12] (reviewed in [20]). Interestingly, also taking into
account increased plasma volume in pregnant bitches, similar concentrations of circulating P4
levels observed in pregnant and non-pregnant bitches [18], further suggest higher luteal ste-
roidogenic activity during pregnancy. Consequently, it was hypothesized that during canine
gestation, some factors, possibly placenta-derived, may act luteotropically by stimulating P4
synthesis [21]. Some authors suggested that increased circulating levels of prolactin (PRL)
could indirectly originate in placental endocrine functions [17, 21, 22]. In fact, PRL is unequiv-
ocally needed for luteal maintenance during the second half of the CL lifespan in the bitch [23,
24]. This has been clearly shown in studies in which PRL secretion was suppressed by dopa-
mine-agonist treatment, resulting in cessation of luteal function, and therefore termination of
pregnancy [23, 24]. Furthermore, average serum PRL levels are typically higher in pregnant
than in non-pregnant bitches [18]. However, because of high individual variations, and ele-
vated PRL concentrations in overtly pseudopregnant bitches, clinical application of PRL as a
reliable marker of gestation is precluded [24–26]. Consequently, the hypothesis was put for-
ward that pregnancy-associated RLN might be responsible for elevated PRL levels during ges-
tation [22]. This was supported by the observation that increased PRL secretion occurs
concomitantly or shortly after the onset of placental RLN production, i.e., soon after implanta-
tion [21]. Observations from other species support this hypothesis. Thus, RLN stimulates
secretion of PRL from the adenohypophysis in pigs [27] and rhesus monkeys [28] in vivo.
Moreover, RLN stimulates PRL release from rat anterior pituitary cells in vitro [29]. However,
the possible involvement of RLN in PRL secretion has never been established for the dog.
Therefore, driven by the hypothesis that RLN might be indirectly involved in endocrine luteo-
tropic regulation of canine CL by affecting hypophyseal PRL synthesis, here, for the first time
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we have investigated the expression and localization of the RLN system (i.e., RLN and its two
receptors: RXFP1 and RXFP2) in the canine anterior pituitary and its co-localization in PRL-
secreting cells. Moreover, as indicated by the foregoing data, there is still a lack of comprehen-
sive information regarding time-dependent expression and localization of the RLN system in
CL of pregnant dogs where RLN could potentially possess a local luteotropic function. For that
reason, we investigated the spatio-temporal expression of the RLN system at both mRNA and
protein levels in the canine CL during the course of pregnancy. The aim of our study was to
investigate if the canine CL and hypophysis have the capability to produce and respond to
RLN. Additionally, possible P4 receptor (PGR)-mediated effects were assessed in bitches
treated with antigestagen (aglepristone) for premature induction of luteolysis/abortion.
Materials and methods
Animals and samples collection
(Study 1) Luteal tissue samples used in this study derived from our previous studies [30, 31].
All experiments were performed in accordance with guidelines of animal welfare legislation
and were approved by the respective authorities, permits nos. II 25.3-19c20-15c GI 18/14 and
VIG3-19c-20/15c GI 18,14 from Justus-Liebig University, Giessen, and permits nos. Ankara
2006/06 and 2008-25-124 from the Faculty of Veterinary Medicine, University of Ankara.
Briefly, healthy, crossbreed, sexually mature bitches (n = 29) were subjected to ovariohys-
terectomy (OHE). Immediately after surgery, tissues were placed in ice-cold PBS and trans-
ported to the laboratory. Using sterile scalpel blades, corpora lutea (CL) were dissected from
surrounding ovarian tissue and processed either for mRNA or protein conservation as
described below. CL were assigned to four study groups, representing the following stages of
pregnancy: pre-implantation (days 8–12, n = 5), post-implantation (days 18–25, n = 5), mid-
gestation (days 35–40, n = 6) and prepartum luteolysis (n = 3). Additionally, in order to termi-
nate gestation, the antigestagen aglepristone (Alizine1, Virbac, Bad Oldesloe, Germany) at a
dose of 10 mg/kg bw s.c.; 2x/24 h apart was administered in dogs at the mid-pregnancy stage
(days 40–45 of pregnancy, n = 10). OHE was done 24h (n = 5) or 72 h (n = 5) after the second
injection. The mean P4 concentrations were reported previously [30] and were as follows: 35.7
±7.9ng/mL during pre-implantation, 29.7±13.2ng/mL at post-implantation, 13.3±8.6ng/mL at
mid-gestation and 2.0±0.9ng/mL during the prepartum luteolysis. Following application of
Alizine, P4 concentrations were as follows: 15.1±6.7ng/mL before the first application; 13.6
±8.2ng/mL after the second treatment; 5.1±2.7ng/mL 24h later; 2.3±1.4ng/mL 48h later and
1.2±0.6ng/mL 72h later. No additional serum samples were available for the present study. The
time point of ovulation was determined by regular measurements of peripheral serum P4 and
vaginal cytology, and was considered to be the day when circulating P4 concentration for the
first time exceeded 5ng/ml. Day 0 of pregnancy was then regarded as the day of mating that
took place 2–3 days after ovulation. The pre-implantation group was determined by the pres-
ence of embryos flushed from the uteri. For the luteolytic group serum P4 was monitored at 6
h intervals starting from day 58 of pregnancy, and a decrease to at least 2-3ng/ml in three con-
secutive measurements was considered as the time of prepartum luteolysis. Canine endothelio-
chorial placenta starts to form immediately following implantation (days 17–18 after mating)
and continues to develop during the first half of pregnancy reaching its maximal size around
day 40 [32, 33]. From this time the utero-placental units are fully developed. Consequently,
relating to the stages of placental development, the post-implantation and mid-gestation
groups used in our study relate to time points in canine pregnancy characterized by the forma-
tion of, and the presence of the fully developed placentae, respectively.
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Additionally, for (Study 2) the anterior part (adenohypophysis) of the pituitary gland was
collected from three (n = 3) bitches (n = 2 in anestrus and n = 1 at diestrus). The tissue material
for this part of the study was derived from other experiments performed at the University of
Zurich under permit numbers 58/2013 and 171/2010 and was shared with us using the 3R
(reduce, replace, refine) approach. The date of last heat had been recorded for each dog. The
stage of the sexual cycle was additionally determined by macroscopic and histological evalua-
tion of reproductive tracts. More accurate timing of the cycle stage was not possible. Purpose-
bred beagle dogs from established breeding facility were used. On the day of euthanasia, the
dogs were sedated with Acepromazine (0.1ml/10kg i.m., Prequillan1, Arovet). An intravenous
catheter was placed and then dogs were euthanized by an intravenous pentobarbital (1ml/3kg
Eutha177, Veterinaria) overdose. Immediately after euthanasia, animals were transported to
the laboratory. For removal of hypophyses, heads were separated from trunks, skulls were
opened, hypophyses were identified and localized in the hypophyseal fossa (Sella turcica, Turk-
ish saddle) of the sphenoid bone and removed. The entire procedure did not exceed 30 min.
Collected tissue samples were processed as described below for either paraffin embedding
or RNA isolation. Thus, following surgery, tissue material was fixed for 24 h in 10% neutral
phosphate-buffered formalin at +4˚C. For the next seven days, samples were incubated at
+4˚C in phosphate-buffered saline (PBS), which was replaced daily. Afterwards, following
dehydration in a graded ethanol series, tissue samples were embedded in paraffin-equivalent
Histo-Comp (Vogel, Giessen, Germany) and subjected to immunohistochemistry (IHC). In
order to extract total RNA, tissue materials were placed in RNAlater1 (Ambion Biotechnology
GmbH, Wiesbaden, Germany) for 24h incubation at +4˚C and subsequently frozen at -80˚C
until total RNA was isolated.
Total RNA isolation, qualitative, conventional PCR, real time (TaqMan)
qPCR and data evaluation
Total RNA from CL and adenohypophyses was extracted, using TRIzol1 reagent following the
manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). A NanoDrop 2000C1 spectro-
photometer (Thermo Fisher Scientific AG, Reinach, Switzerland) was used to assess the quality
and quantity of isolated RNA. To eliminate contamination by genomic DNA, DNase treat-
ment was performed using RQ1 RNase-free DNase (Promega, Duebendorf, Switzerland)
according to the supplier’s instructions. Afterwards, using random hexamers as primers and as
described before [34, 35], cDNA was prepared by the reverse transcription (RT) reaction.
Reagents for RT were provided by Applied Biosystems by Thermo Fisher (Carlsbad, CA,
USA). The final amount of cDNA of each sample corresponded to 100 ng of DNase-treated
total RNA. Reactions were conducted in an Eppendorf Mastercycler1 (Vaudaux-Eppendorf
AG, Basel, Switzerland). Based on published canine CDS sequences, primers (used in conven-
tional, qualitative PCR and real time PCR) and TaqMan1 probes labeled with 6-carboxyfluor-
escein (6-FAM) and 6-carboxytetramethylrhodamine (TAMRA) were designed with Primer
Express Software ver. 2.0 (Applied Biosystems) for three target genes: RLN, RXFP1,RXFP2,
and a reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). A complete list of
primers and TaqMan probes is provided in Table 1. Self-designed primers and TaqMan probes
were purchased from Microsynth (Balgach, Switzerland). Canine-specific primers and probe
mixtures for two reference genes, B-ACTIN (Prod. No. Cf03023880_g1) and CYCLOPHILIN A
(Prod. No. Cf03986523-gH), were commercially available and purchased from Applied Biosys-
tems. The efficiencies of the PCR assays were determined by the CT slope method assuring
approximately 100% reaction efficiency. Selected, randomly chosen amplicons of all target
genes were sent for commercial sequencing (Microsynth).
Canine luteal and hypophyseal RLN system
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Conventional, qualitative RT-PCR was performed using total RNA isolated from the ante-
rior pituitary glands to verify expression of the RLN-system. The annealing temperature was
set to 56˚C. The hot start PCR reaction using the GeneAmp Gold RNA PCR Kit (Applied Bio-
systems, Foster City, CA, USA) was done as previously described [34]. Following this reaction,
products were separated by electrophoresis using a 2% agarose gel and stained with ethidium
bromide. Amplicons of all target genes were sent for commercial sequencing (Microsynth).
Regarding luteal expression of the RLN-system, an automated fluorometer ABI PRISM
7500 Sequence Detection System (Applied Biosystems) was used for semi-quantitative analysis
of RLN-, RXFP1- and RXFP2-mRNA expression in each sample. Five μl of cDNA correspond-
ing to 100 ng total RNA were used in a 25μl reaction mixture that consisted additionally of:
200 nM TaqMan Probe, 300 nM of each primer and 12.5μl Fast Start Universal Probe Master
(ROX)1 (Roche Diagnostics, Mannheim, Germany). Each sample was run in duplicates in
96-well optical plates (Applied Biosystems). As negative controls, autoclaved water and the
‘minus-RT controls’ (i.e., samples treated with DNase but not subjected to RT) instead of
cDNA were used. Amplification was done under the following conditions: initial denaturation
for 10 min at 95˚C, followed by 40 cycles for 15s at 95˚C and 1 min at 60˚C. Three reference
genes, i.e., GAPDH, B-ACTIN and CYCLOPHILIN A, served for normalization of expression
levels of the target genes, which were calculated using the comparative CT method (ΔΔCT
method) in accordance with the ABI 7500 Fast Real-Time PCR System protocol provided by
the manufacturer and as published previously [34, 35].
Immunohistochemistry (IHC)
As previously reported [15], due to the fact that specific or cross-reacting antibodies were not
commercially available, canine-specific polyclonal anti-RXFP1 and anti-RXFP2, custom-made
antisera were generated (Eurogentec, Seraing, Belgium) in guinea pigs immunized against the
following peptide sequences: RXFP1: C+AELDLGSNKIENLPP, amino acids 217–231 and C+-
ATEIRNQVKKEMILA, amino acids 532–546 of the canine RXFP1 sequence with GenBank
accession number KY980750; RXFP2: C+QTSEVRNPIGREVAV, amino acids 605–619 and C
+LLHKHRRKSIFKTKK, amino acids 688–702 of the canine RXFP2 sequence with GenBank
accession number NM_001005870.1. Regarding detection of RLN, the anti-RLN, canine-spe-
cific polyclonal affinity purified anti-RLN custom-made antibody was generated in guinea pigs
Table 1. List of primers used for real time (TaqMan) PCR.
Primers and TaqMan probes used for semi-quantitative RT-PCR
Primer Accession number Primer sequence Product length (bp)
GAPDH AB028142 Forward: 5’-GCT GCC AAA TAT GAC GAC ATC A-3’ 75
Reverse: 5’-GTA GCC CAG GAT GCC TTT GAG-3’
TaqMan Probe: 5’-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3’
RLN NM_001003132.1 Forward: 5’-TGC TAG GTG TCT GGC TGC TAC TAA-3’ 94
Reverse: 5’-CGG ACA TAA TCA CGA CCA CAT G-3’
TaqMan Probe: 5’-ACT TCC CAG AGA GAT CCC AGC CAC G-3’
RXFP1 KY980750 Forward: 5’-GGC ACC AAT GGA GTG TGT TTC-3’ 102
Reverse: 5’-TGC CGC CAA GTT AAC ACC AA-3’
TaqMan Probe: 5’-TAC TGG AGC CCA GAT TTA TTC GGT GGC-3’
RXFP2 NM_001005870.1 Forward: 5’-CCC TGT GGG AAT CTT ACC AAG T-3’ 98
Reverse: 5’-GTG TCA CCA CAG TTG TCC TCA TC-3’
TaqMan Probe: 5’-TTA CCC CGT GCT TTT CAC TGT GAT GGC-3’
Reverse: 5’-GGC AGT CTG CAC AAC AAA GG-3’
https://doi.org/10.1371/journal.pone.0191374.t001
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(Eurogentec) and targeted against the IPATDDKKLKAC peptide sequence, amino acids 23–
34 of the canine RLN sequence with GenBank accession number NM_001003132.1. A cysteine
(indicated as C+) amino acid was incorporated at the N- or C-terminal position of the peptide
to target the coupling site on the carrier protein (Eurogentec). PRL in the canine adenohy-
pophysis was detected using polyclonal rabbit anti-PRL antibody (ab186522, Abcam, Cam-
bridge, UK) and macrophages in canine CL were detected using polyclonal rabbit anti-Major
Histocompatibility Complex Class II (MHCII) antibody (orb101661, Biorbyt Limited, Cam-
bridge, UK).
The immunohistochemistry procedure was carried out in accordance with our previously
published protocol [34, 36]. In brief, tissue sections (2–3 μm in thickness) were mounted on
SuperFrost microscope slides (Menzel-Glaeser, Braunschweig, Germany), dewaxed in xylene
and rehydrated in a graded ethanol series. After washing for 5 min under tap water, antigens
were retrieved in 10 mM citrate buffer pH 6.0, initially for 5 min at ambient temperature, then
for 15 min in buffer heated in a microwave oven at 600W. Finally, slides were cooled down for
20 min. For RXFP1 localization in luteal samples, instead of heat-induced antigen retrieval,
enzymatic digestion was done using 0.25% pepsin (Sigma-Aldrich Chemie GmbH, Buchs,
Switzerland) in 10 mM HCl for 10 min at 37˚C. Following antigen retrieval, slides were rinsed
in tap water and placed in methanol with the addition of 0.3% hydrogen peroxide for quench-
ing endogenous peroxidase activity. Subsequently, slides were washed for 5 min in IHC buffer/
0.3% Triton X, pH 7.2–7.4 (0.8 mM Na2HPO4, 1.47 mM KH2PO4, 2.68 mM KCl, 137 mM
NaCl) and nonspecific binding of antibodies was blocked by incubating with 10% goat serum
for 20 min. Afterwards, samples were incubated overnight with primary antibodies at the fol-
lowing dilutions: a) for CL: 1:500 for anti-RLN antibody, 1:750 for anti-RXFP1 and 1:1000 for
anti-RXFP2 canine-specific antisera, and 1:200 for anti-MHCII antibody; b) for hypophysis:
1:750 for anti-RLN antibody, 1:9000 for anti-PRL antibody, 1:1500 for anti-RXFP1 and 1:1000
for anti-RXFP2 canine-specific antisera. The specificity of IHC was evaluated using: 1) pre-
immune guinea pig serum at the same dilution and protein concentration as the primary anti-
serum against RXFP1 and RXFP2, and 2) non-immune guinea pig IgG (for RLN) or rabbit
IgG instead of the primary antibody against PRL and MHCII, as negative (isotype) controls.
On the following day, after washing in IHC buffer/0.3% Triton X, slides were incubated for 30
min with biotinylated secondary antibodies at 1:100 dilution.
The goat anti-guinea pig secondary antibodies were used for detection of the RLN-system.
For detection of PRL and MHCII goat anti-rabbit secondary antibodies were applied (both
from Vector Laboratories, Burlingame, CA, USA). Afterwards, with washing steps in between,
the streptavidin-peroxidase Vectastain ABC kit (Vector Laboratories) was added to enhance
signals. After 30 min, and renewed washing in IHC buffer, peroxidase activity was detected
using the Liquid DAB+ substrate kit (Dako, Basel, Switzerland). Following detection, hema-
toxylin served to counterstain the samples. After washing under tap water and dehydration in
a graded ethanol series, slides were mounted in Histokit (Assistant, Osterode, Germany).
For localization of PRL and the RLN system in the adenohypophysis, 2 series (three and
four slides, respectively) of consecutive sections of tissue were cut. Of these, the first two slides
of each series were stained with hematoxylin and eosin (HE) and immunohistochemically for
detection of PRL. The next slides were used in the IHC protocol for detection of RLN or
RXFP1 and RXFP2.
Statistical analysis
Normalization of data was done by logarithmic transformation. The geometric means (Xg) ±
geometric standard deviation (SD) were calculated for the analysis of target gene expression.
Canine luteal and hypophyseal RLN system
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Next, in order to assess the effects of gestational stage on luteal RLN-system mRNA expression,
a parametric one-way analysis of variance (ANOVA) was applied. In case of P<0.05 the
Tukey-Kramer multiple comparisons post-test was performed and each pregnancy stage was
compared with one another.
Regarding experimental groups treated with aglepristone, these were analyzed with refer-
ence to a non-treated mid-gestation group, which served as a non-treated control. Then,
ANOVA was followed by Dunnett’s multiple comparisons test when P<0.05. Each of the
treated groups (i.e., 24h and 72h after aglepristone treatment) was then compared with the
mid-gestation group. All statistical analyses were done using the statistical software program
GraphPad 3.06 (GraphPad Software, San Diego, CA, USA).
Results
(Study 1.1) Time-dependent expression of the RLN system in the canine CL
throughout pregnancy
The expression of transcripts encoding for RLN system members was detectable at all selected
time points during pregnancy. RLN was significantly modulated in a time-dependent manner
(P<0.0001) (Fig 1A). Its expression was upregulated from pre-implantation towards post-
implantation (P<0.01), stayed elevated until mid-gestation and decreased significantly at pre-
partum luteolysis (P<0.001). The mRNA expression of both receptors did not change signifi-
cantly over time (P>0.05); the mRNA levels of RXFP2 varied widely individually and were
below detection limits in two dogs, one from the pre-implantation stage and one from mid-
gestation (Fig 1B and 1C).
(Study 1.2) The effect of antigestagen-treatment on luteal expression of the
RLN system
The effects of antigestagen treatment on luteal expression of the RLN system were assessed in
mid-pregnant dogs. As indicated elsewhere, samples from untreated mid-pregnant dogs were
used as controls. The RLN mRNA levels were affected by antigestagen and already decreased sig-
nificantly (P<0.01) 24h after the second treatment (Fig 2A) and remained low at 72h (P<0.01).
As for RLN receptors, whereas the luteal expression of RXFP1was not affected by aglepristone
(P = 0.32) (Fig 2B), the mRNA levels of RXFP2 varied widely individually but decreased strongly
24h after the second treatment (P<0.01) (Fig 2C), remaining below the detection limits in two
dogs. Similarly, at 72h after the second aglepristone application strong individual variations in
RXFP2mRNA were observed that were not significantly different (P>0.05) (Fig 2C).
(Study 1.3) Immunohistochemical detection of the RLN system in canine
CL throughout pregnancy
IHC was applied for detection of RLN, RXFP1 and RXFP2 localization at the protein level in
canine CL at selected time points during pregnancy. Custom-made canine-specific antibody
generated against RLN strongly stained luteal cells (Fig 3A–3D). Although large individual var-
iations were observed, the signals appeared stronger at mid-gestation (Fig 3C) and prepartum
luteolysis (Fig 3D). Other luteal compartments, e.g., stroma and vascular components, stained
weakly. The immunolocalization of RXFP1 consisted mainly of luteal cells (Fig 4A–4D), how-
ever, the signal intensity appeared weaker at prepartum luteolysis (Fig 4D). Additionally,
RXFP1 was found in endothelial cells (indicated in Fig 4A and 4C) and luteal macrophages
(Fig 4A–4D). On the other hand, RXFP2 was detected primarily in interstitial cells (Fig 5A–
5D), especially those localized in close proximity to blood vessels, throughout all stages of
Canine luteal and hypophyseal RLN system
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Fig 1. Expression of (A) RLN, (B) RXFP1 and (C) RXFP2 in canine CL at selected time points of pregnancy. Data
are presented as geometric means Xg ± SD. ($) = P<0.01, ($$) = P<0.001.
https://doi.org/10.1371/journal.pone.0191374.g001
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Fig 2. Antigestagen (aglepristone) effects on luteal expression of the RLN system (A) RLN, (B) RXFP1 and (C)
RXFP2), as determined by real time (TaqMan) PCR. Data are presented as geometric means Xg ± SD. Bars with
different letters differ at P<0.01 compared to the mid-gestation group as a non-treated control.
https://doi.org/10.1371/journal.pone.0191374.g002
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pregnancy. Detection of MHCII, a marker of antigen-presenting cells, shown recently to be
predominantly localized in macrophages localized close to luteal blood vessels in canine CL
[37], was performed in order to more easily differentiate cell types within canine CL (Fig 5E).
Accordingly, the interstitial cells staining strongly for RXFP2 were identified as luteal macro-
phages (Fig 5E and 5F). In addition, whereas only weak signals were found in luteal cells from
pre-implantation until mid-gestation, during prepartum luteolysis these cells clearly stained
for RXFP2 (Fig 5A–5D). Occasionally, for all antibodies some background signals were
observed in erythrocytes.
Fig 3. Representative microphotographs of immunohistochemical (IHC) localization of RLN in the canine CL at selected time points of
pregnancy. Pre-implantation (A), post-implantation (B), mid-gestation (C) and at prepartum luteolysis (D). RLN is localized to the lutein cells
(open arrows in (A–D)). There is no background staining in the isotype control (insert to (D)).
https://doi.org/10.1371/journal.pone.0191374.g003
Canine luteal and hypophyseal RLN system
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(Study 2) Expression and localization of PRL and the RLN system in canine
adenohypophysis
Following the removal of hypophyses from the skull, anterior and posterior parts of the organ
(adenohypophysis and neurohypophysis) were identified and separated (Fig 6A–6D).
Fig 4. Representative microphotographs of immunohistochemical (IHC) localization of RXFP1 in the canine CL at selected time points of
pregnancy. Pre-implantation (A), post-implantation (B), mid-gestation (C) and at prepartum luteolysis (D). RXFP1 is localized to the luteal cells (open
arrows in (A-D)), endothelial cells (solid arrows in A and C) and macrophages (open arrowheads in (A-D)). There is no background staining in the
isotype control (insert to (D)).
https://doi.org/10.1371/journal.pone.0191374.g004
Canine luteal and hypophyseal RLN system
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Fig 5. Representative microphotographs of immunohistochemical (IHC) localization of RXFP2 in the canine CL at selected time
points of pregnancy. Pre-implantation (A), post-implantation (B), mid-gestation (C) and at prepartum luteolysis (D); consecutive
sections were stained against MHCII (E) and RXFP2 (F). While only weak RXFP2 signals were found in luteal cells from pre-
implantation until mid-gestation, during prepartum luteolysis clearly detectable staining is present in these cells (open arrows in A-D).
The detection of MHCII was performed in order to more easily differentiate cell types within canine CL. Accordingly, RXFP2 was
Canine luteal and hypophyseal RLN system
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Expression of the RLN system was confirmed in the canine adenohypophysis by qualitative,
conventional PCR (Fig 6E), although the intensity of RLN and RXFP2 signals appeared weaker
than for RXFP1. Their specificity was, however, confirmed by sequencing. In order to investi-
gate the hypophyseal localization of the RLN system and PRL at the protein level, IHC was
applied. The HE staining allowed us to distinguish between the acidophilic and basophilic
compartments of the gland. Consequently, PRL staining was found in some acidophilic cells in
consecutively stained tissue sections (Fig 7A, 7B, 7D and 7E). This localization pattern was fur-
ther observed for RLN, which was co-localized with PRL in the same cellular components (Fig
7C). However, additional RLN signals were also detected in other hypophyseal cells, which
remained negative for PRL. RLN receptors were ubiquitously distributed in the canine adeno-
hypophysis, in both acidophilic and basophilic compartments, with signals appearing more
prominent for RXFP1 than RXFP2 (Fig 7F and 7G). There was no background staining
observed in negative/isotype controls (Fig 7H–7K).
Discussion
With this study, we aimed to evaluate the presumptive luteotropic function of RLN in the
canine species. Therefore, the basic capability of canine CL to produce and respond to RLN
was assessed at selected time points of pregnancy from the pre-implantation stage until prepar-
tum luteolysis. Moreover, here for the first time, the hypophyseal cellular expression and local-
ization of the RLN system in the dog is described, providing further insights into possible
RLN-mediated effects on PRL secretion in the dog.
In Study 1, luteal development was associated with increasing expression of RLN, but not of
its receptors. The highest RLN mRNA levels were observed in fully functional CL during post-
implantation and at mid-gestation, apparently coinciding with the maximal steroidogenic
capabilities of the CL. Thus, at least a supporting role of locally-produced RLN in regulating
canine CL is suggested. The acute suppression of luteal RLN expression during normal and
antigestagen-induced luteolysis implies a functional positive feedback loop between RLN and
P4. Possible interactions with downstream responders of P4, or other P4-mediated regulatory
pathways, could be additionally involved. The possible luteal function of RLN appears to
depend, however, more strongly on its own expression, than on the availability of its receptors,
i.e., RXFP1 and RXFP2, which seem to be constantly present during most of the luteal life
span.
A wide spectrum of RLN targets within the canine CL was observed in this study, implying
that the functionality of RLN varies among luteal components. The strong expression of the
RLN system, especially RLN and RXFP1, in steroidogenic cells indicates possible direct effects
of RLN on their function. Moreover, RLN seems to be involved in regulating the function of
luteal vessels, acting particularly on endothelial cells, in which predominantly RXFP1 was
clearly represented. Knowing that vasodilatory properties of RLN [38, 39] are related to stimu-
lation of nitric oxide (NO) production [reviewed in [40]], it seems plausible that RLN could
also participate in regulation of the luteal microcirculation in the dog. Furthermore, RLN was
shown to increase expression of vascular endothelial growth factor (VEGF) in human endome-
trial cells [3]. Considering that VEGF is expressed in a time-dependent manner in canine CL
and that its expression increases post-implantation [41], a possible interaction between these
two systems (i.e., the RLN and VEGF systems) could also apply to the canine species. Never-
theless, the characteristics of this interplay need further clarification.
found in interstitial cells, mostly those localized close to blood vessels expressing MHCII that were identified as macrophages (black
arrows in E and F, open arrowheads in A-D). There is no background staining in the isotype control (insert to (D)).
https://doi.org/10.1371/journal.pone.0191374.g005
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Fig 6. Isolation of hypophysis and adehohypophyseal expression of RLN-system. Representative photographs of opened skull of a dog before (A, dorsal view
and B, dorsocaudal view), and after (C, dorsocaudal view) removal of the brain including the hypophysis (D). The hypophysis was localized in the saddle-shaped
depression of the sphenoid bone, so-called Turkish saddle (Sella turcica). Proximally, directly above the pituitary gland, the optic chiasm can be localized. Parts
of the optic chiasm are attached to the isolated hypophysis (D). E) Expression of RLN, RXFP1,RXFP2 and GAPDH in canine adenohypophysis by conventional,
qualitative PCR. The mRNA of all RLN system members was detectable, with RLN and RXFP2 signals appearing weaker than those for RXFP1.
https://doi.org/10.1371/journal.pone.0191374.g006
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Fig 7. Hematoxylin-eosin (HE) staining (A, D) and immunolocalization of PRL (B, E) and RLN system (C, F, G) in canine
adenohypophysis (two series of consecutive sections are presented: A-C and D-G). HE staining was performed in order to distinguish
basophilic (solid arrows in A and D) and acidophilic hypophyseal cells (open arrows in A and D). The latter include PRL-secreting cells,
so-called lactotrophs, identified additionally by IHC with anti-PRL antibody (open arrows in B and E). RLN signals were observed in
lactotrophs (open arrows in C) and in other hypophyseal cells, which remained negative for PRL (solid arrows in C). RXFP1 and RXFP2
Canine luteal and hypophyseal RLN system
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An interesting finding from our study was the detection of RLN receptors, mainly RXFP2,
in luteal macrophages. This observation implies possible involvement of RLN in regulating
luteal immune cells. In accordance with this, by supporting vascular formation, luteal macro-
phages were shown to play a role in coordinating the development of human CL [42]. In
another in vitro study, RLN mediated release of cytokines from human decidual macrophages
[43]. Taking these facts into account, our results suggest that RLN-mediated effects on luteal
macrophages could possibly be exerted through interaction with RXFP2. It should be noted,
however, that INSL3, formerly known as relaxin-like factor (RLF), is a cognate agonist for
RXFP2, which is a minor receptor for RLN. Thus, the possible involvement of INSL3 in regula-
tion of luteal macrophages cannot be excluded and indicates a direction for future studies.
Administration of a P4 receptor (PGR) antagonist, aglepristone, to dogs at mid-gestation
results in activation of the placental prostaglandin system, premature luteolysis and finally in a
rapid decline of P4 [44]. Apart from RLN, the expression of one of its receptors, RXFP2, was
also strongly affected by antigestagen treatment. The involvement of P4 signaling in this pro-
cess appears plausible. This would resemble the situation observed in vitro with human granu-
losa cells, which when treated with a PGR antagonist responded with a dramatic decline in
secretion of estrogens, P4 and RLN [45]. It is noteworthy, however, that although PGR-medi-
ated effects appear to affect luteal and placental [15] RLN expression in dogs, they do not seem
to interfere directly with circulating RLN [46, 47] and, thus, to be relevant for the overall sup-
ply of RLN.
Next, following observations made in other species, i.e., pigs and monkeys, in which posi-
tive, RLN-mediated effects on hypophyseal PRL secretion were observed [27, 28], we were
prompted in Study 2 to investigate the presence and spatial association of the RLN system and
PRL in the canine pituitary gland. This allowed us to address the hypothesis of potential indi-
rect luteotropic function of RLN by stimulating hypophyseal PRL secretion in dogs.
It needs to be emphasized that the tissue material (i.e., canine pituitary glands) used in our
study was not obtained with respect to a particular reproductive stage since the dogs were not
euthanized for the purpose of this study. Nevertheless, we were able to verify the presence of
the RLN system in adenohypophyses from dogs, both at anestrus and diestrus. The presence of
its respective transcripts and proteins was clearly confirmed. Finally, co-localization with PRL-
expressing cells was established. Based on the available literature [48], PRL is present in the
serum of anestric dogs. Therefore, we expected to detect PRL in pituitary cells referred to as
lactotrophs in the tissues collected during anestrus. For better differentiation of particular cel-
lular components, the first consecutive sections stained for target proteins were assessed by
HE staining. With regards to the RLN system, the signals for RXFP1 appeared stronger than
for RXFP2, at both the mRNA and protein levels. Both receptors were found widely distributed
in both cell types, i.e., acidophilic as well as basophilic hypophyseal cells. They clearly stained
in lactotrophs, which were identified immunohistochemically with anti-PRL antibody. This
strongly indicates that RLN, interacting with its receptors, could affect the function and secre-
tory activity of the canine adenohypophysis. Notably, in addition to the above-cited in vivo
studies performed in pigs and rhesus monkeys [27, 28], Sortino et al. [29] observed an increase
in PRL release from rat anterior pituitary cells in vitro following stimulation with RLN, imply-
ing a central role of RLN in modulating PRL secretion in these species. That response occurred
due to RLN-induced accumulation of cyclic adenosine monophosphate (cAMP) [49, 50].
Interestingly, the RLN effect on cAMP can be abolished by dopamine [49], a potent PRL
stained extensively in hypophyseal cells with signals appearing more prominent for RXFP1 than RXFP2 (open arrows in F and G,
respectively). There is no background staining in the isotype controls (H, I, J, K).
https://doi.org/10.1371/journal.pone.0191374.g007
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Fig 8. A schematic model depicting proposed aspects of autocrine, paracrine and endocrine functions of RLN in canine reproductive tissues,
emphasizing its role as a possible luteotropic factor. (1) Local, luteal RLN acts in an auto/paracrine manner on steroidogenic, endothelial and
immune cells. (2) Circulating RLN of placental origin acting as an endocrine factor. (3) Adenohypophysis, as a target of placental RLN during
pregnancy. Additionally, locally produced hypophyseal RLN may exert auto/paracrine effects on pituitary cells (4); possible interactions of RLN
with production and secretion of other hypophyseal hormones, including PRL are suggested. (5) PRL originating from the hypophysis is the main
Canine luteal and hypophyseal RLN system
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inhibitor. In this context, it appears noteworthy that dopamine-agonists (e.g., cabergoline, bro-
mocriptine) are routinely used in veterinary practice to decrease PRL levels and interrupt lac-
tation in overtly pseudopregnant bitches.
Cumulatively, based on the presented results herein, the involvement of RLN in regulating
the canine adenohypophysis, and possibly its PRL secretion, is strongly implied. Regrettably,
owing to the lack of temporal accuracy in tissue collections, cycle and/or pregnancy stage-
related effects could not be assessed and remain open for future studies. Moreover, since our
study only provided hints for possible relationships among adenohypophyseal hormones, the
effects of RLN on secretion of other pituitary hormones in the dog also remain to be
elucidated.
In conclusion, by revealing the spatial and temporal expression of the RLN system in the
CL of pregnant dogs and localizing it in the anterior pituitary gland, herein new insights are
provided into canine reproductive physiology.
Although luteal RLN does not seem to contribute significantly to overall circulating levels
of this hormone during pregnancy, our data suggest that by acting in an autocrine- and para-
crine manner, RLN could possibly be directly involved in support of luteal steroidogenic func-
tion in the dog. The endocrine route could involve the interaction of placental RLN with its
luteal receptors. Additionally, by interacting with endothelial cells and macrophages, RLN
could potentially be involved in regulation of the microvascular system in canine CL.
A schematic representation of the distribution pattern of RLN system in canine reproduc-
tive tissues and its possible interactions is shown in Fig 8.
The interplay between luteal RLN and P4 certainly deserves further attention since natural
or induced withdrawal of P4 during luteolysis had a negative feedback on luteal RLN expres-
sion. The indirect effects of RLN on luteal function may rely on stimulation of PRL secretion
from the adenohypophysis (Fig 8). The evident presence of RXFP1 and RXFP2 proves that the
adenohypophysis is an important target for RLN. It appears especially plausible for lactotrophs
since the PRL serum level increases significantly after RLN rises in the blood of a pregnant
bitch (Fig 8).
Although a direct connection between RLN and PRL remains to be convincingly demon-
strated, here we provide a novel aspect of RLN action with respect to the canine
adenohypophysis.
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